Clinical Data Taps New Sales VP for PGxHealth; Gene Logic Fleshes Out Board; GeneNews Updates Brass; and Others | GenomeWeb
This article has been updated from a previous version, which incorrectly reported that James Shaffer was previously employed at Shire, rather than New River Pharmaceuticals.
 
NEW YORK (GenomeWeb News) — Gene Logic has added David Urdal and Mark Gabrielson to its board of directors, while Jules Blake has retired from the board, the company said this week.
 
Urdal is currently senior vice president and CSO at Dendreon. Previously he was president of Immunex.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.